These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15506434)

  • 1. [Inhibitory effect of nitric oxide on oxidation of low-density lipoprotein].
    Fujioka Y; Taniguchi T; Yokoyama M; Ishikawa Y
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():493-5. PubMed ID: 15506434
    [No Abstract]   [Full Text] [Related]  

  • 2. Antioxidant effects of nitric oxide and nitric oxide donor compounds on low-density lipoprotein oxidation.
    Goss SP; Kalyanaraman B; Hogg N
    Methods Enzymol; 1999; 301():444-53. PubMed ID: 9919593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights.
    Rubbo H; O'Donnell V
    Toxicology; 2005 Mar; 208(2):305-17. PubMed ID: 15691594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The formation of some antigenic epitopes in oxidized human low-density lipoprotein is inhibited by nitric oxide.
    Seccia M; Perugini C; Bellomo G
    Biochem Biophys Res Commun; 1997 Mar; 232(3):613-7. PubMed ID: 9126322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice.
    Napoli C; Ackah E; De Nigris F; Del Soldato P; D'Armiento FP; Crimi E; Condorelli M; Sessa WC
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12467-70. PubMed ID: 12209007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of diosgenin in the hyperlipidemic rat model and in human vascular endothelial cells against hydrogen peroxide-induced apoptosis.
    Gong G; Qin Y; Huang W; Zhou S; Wu X; Yang X; Zhao Y; Li D
    Chem Biol Interact; 2010 Mar; 184(3):366-75. PubMed ID: 20149787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NO and atherosclerosis].
    Ohtani K; Egashira K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():544-7. PubMed ID: 15506446
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of oxidative modifications in atherosclerosis.
    Stocker R; Keaney JF
    Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical constituents of Baeckea frutescens leaves inhibit copper-induced low-density lipoprotein oxidation.
    Kamiya K; Satake T
    Fitoterapia; 2010 Apr; 81(3):185-9. PubMed ID: 19699785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesis.
    Miller YI; Choi SH; Fang L; Tsimikas S
    Subcell Biochem; 2010; 51():229-51. PubMed ID: 20213546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant effect of polyphenolic glabridin on LDL oxidation.
    Carmeli E; Fogelman Y
    Toxicol Ind Health; 2009; 25(4-5):321-4. PubMed ID: 19651803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of ixidized low density lipoprotein in atherosclerosis].
    Hansen PR
    Ugeskr Laeger; 1996 May; 158(19):2706-10. PubMed ID: 8744072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives.
    Rubbo H; Parthasarathy S; Barnes S; Kirk M; Kalyanaraman B; Freeman BA
    Arch Biochem Biophys; 1995 Dec; 324(1):15-25. PubMed ID: 7503550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide inhibits prooxidant actions of uric acid during copper-mediated LDL oxidation.
    Sanguinetti SM; Batthyány C; Trostchansky A; Botti H; López GI; Wikinski RL; Rubbo H; Schreier LE
    Arch Biochem Biophys; 2004 Mar; 423(2):302-8. PubMed ID: 15001394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and low-density lipoprotein oxidation.
    Hogg N; Kalyanaraman B
    Free Radic Res; 1998 Jun; 28(6):593-600. PubMed ID: 9736311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-derived relaxing factor (nitric oxide), lipoprotein oxidation and atherosclerosis.
    Bruckdorfer KR; Jacobs M; Rice-Evans C
    Biochem Soc Trans; 1990 Dec; 18(6):1061-3. PubMed ID: 2088806
    [No Abstract]   [Full Text] [Related]  

  • 19. Antioxidants and atherosclerotic heart disease.
    Diaz MN; Frei B; Vita JA; Keaney JF
    N Engl J Med; 1997 Aug; 337(6):408-16. PubMed ID: 9241131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal vasoconstriction induced by oxidized LDL is inhibited by scavengers of reactive oxygen species and L-arginine.
    Rahman MM; Varghese Z; Fuller BJ; Moorhead JF
    Clin Nephrol; 1999 Feb; 51(2):98-107. PubMed ID: 10069645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.